Patent intelligence · US
US 10167256
Psychotrophic agents and uses thereof
Psychotrophic agents and uses thereof
Patent details — US 10167256
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 1, 2019
- Expiration
- Dec 27, 2038
- Applicant
- LB PHARMACEUTICALS INC.
- Claims
- 11
- CPC classes
- A61K, A61K31/166, A61K31/40, A61K45/06
Quick answer
US 10167256 (Psychotrophic agents and uses thereof) is held by LB PHARMACEUTICALS INC.. Status: granted. Granted Jan 1, 2019. Expires Dec 27, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LB PHARMACEUTICALS INC.
- Grant date
- Expiration
- Claims
- 11
- CPC classes
- A61K, A61K31/166, A61K31/40, A61K45/06, A61P, A61P25/18
More from LB PHARMACEUTICALS INC.
Related pharmaceutical patents in our USPTO index.
-
US 12060327
Psychotropic agents and uses thereof
granted -
US 11713295
Psychotropic agents and uses thereof
granted -
US 11377421
Psychotropic agents and uses thereof
granted -
US 11040943
Psychotropic agents and uses thereof
granted -
US 10689338
Psychotropic agents and uses thereof
granted -
US 10259786
Psychotropic agents and uses thereof
granted
Frequently asked questions
What is US patent 10167256?
US 10167256 (Psychotrophic agents and uses thereof) is held by LB PHARMACEUTICALS INC.. Status: granted. Granted Jan 1, 2019. Expires Dec 27, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10167256?
LB PHARMACEUTICALS INC. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 7 pharmaceutical patents for this assignee.
When does US 10167256 expire?
Our index shows an expiration date of Dec 27, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.